États-Unis · Plateformes & données · MarketBeat

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

Publié par MarketBeat · États-Unis il y a 1 h

Wells Fargo & Company decreased their price objective on BioNTech from $140.00 to $125.00 and set an "overweight" rating for the company in a report on Wednesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

Partager

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit